Crossref
Rethinking sarcopenia screening in middle age—The 2025 AWGS consensus and its implications for cognitive health
Aging Pathobiology and Therapeutics · 25.09.2026 · 8 (3)
DOI: 10.31491/apt.2026.09.238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Pathobiology and Therapeutics, online erschienen am 30.09.2026. Verfasst von Chieh Chen und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chen, C., & Liao, D. (2026). Rethinking sarcopenia screening in middle age—The 2025 AWGS consensus and its implications for cognitive health. Aging Pathobiology and Therapeutics, 8(3). https://doi.org/10.31491/apt.2026.09.238
Vancouver
Chen C, Liao D. Rethinking sarcopenia screening in middle age—The 2025 AWGS consensus and its implications for cognitive health. Aging Pathobiology and Therapeutics. 2026;8(3). doi:10.31491/apt.2026.09.238
BibTeX
@article{Chen2026,
author = {Chen, Chieh and Liao, Da-Ming},
title = {Rethinking sarcopenia screening in middle age—The 2025 AWGS consensus and its implications for cognitive health},
journal = {Aging Pathobiology and Therapeutics},
year = {2026},
volume = {8},
number = {3},
doi = {10.31491/apt.2026.09.238}
}
EUVIMED